Maria-Luisa Maccecchini
President and CEO at Annovis Bio Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Annovis Bio Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Annovis Bio Inc. June 17, 202693.8%
-
Lantern Pharma Inc. September 19, 202598.6%
-
Annovis Bio Inc. June 17, 202596.1%
-
Annovis Bio Inc. June 13, 202497.7%
-
Lantern Pharma Inc. June 13, 202499.3%
-
Annovis Bio Inc. June 16, 202399.1%
-
Lantern Pharma Inc. June 16, 202389.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 28, 2025 | Annovis Bio Inc. | Open-market purchase | +97,561 | $2.05 | $200,000 |
| Jun 4, 2025 | Annovis Bio Inc. | Grant or award | +46,000 | $3.37 | $155,020 |
| Mar 31, 2024 | Annovis Bio Inc. | Gift | −10,000 | — | — |
| Mar 31, 2024 | Annovis Bio Inc. | Gift | −10,000 | — | — |
| Mar 28, 2024 | Annovis Bio Inc. | Gift | −10,000 | — | — |
| Nov 20, 2023 | Annovis Bio Inc. | Grant or award | +41,186 | $6.07 | $249,999 |
| Apr 24, 2023 | Annovis Bio Inc. | Gift | −3,000 | — | — |
| Apr 7, 2023 | Annovis Bio Inc. | Grant or award | +20,000 | $12.61 | $252,200 |
| Feb 6, 2023 | Annovis Bio Inc. | Option exercise | +52,755 | $0.14 | $7,386 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.